- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04064372
Mindful Response to Adversity: A Brief Stress Resilience Training
Mindful Response to Adversity: A Brief Stress Resilience Training for Improving Mental Health in Students
Study Overview
Status
Conditions
Detailed Description
The investigators will conduct an intervention study with the aim of improving stress resilience and mental health outcomes in at-risk freshman students. The investigators will also work closely with institutional officials to assess whether the intervention can improve student well-being. Specifically, the project aims to teach freshman students (who are at high risk for depression) skills in how to foster a mindful response to adversity at the beginning of the school term, along with periodic support reminders (via text message) during high stress/vulnerability periods over the course of the semester. The investigators will adopt a randomized controlled trial approach to rigorously evaluate whether this intervention can be adopted as a standard onboarding program for all incoming freshman students during the first weeks of orientation on the CMU campus. Participants will come for the study session and provide a dried blood spot sample and complete a battery of self-report questionnaires.
Participants will attend a group training session, led by a professional instructor, about responding to adversity, which will include a description of the skills, a writing and sharing activity focused on the proposed approach, and a practice session. Following the training, participants will be instructed to practice the skills that the participants just learned during a group version of a standard stress-induction task called the Trier Social Stress Task (the TSST-G). Salivary cortisol measures will be collected throughout the TSST-G.
The treatment condition will be trained in techniques designed to teach a "mindful approach to adversity". These techniques will include: normalizing, attention, equanimity, non-judgment, de-centering, accepting of experiences, and impermanence. Participants will be instructed on the mindset, asked to write about an instance of non-judgment and share with a partner, and then guided through a short training designed to practice each skill.
The control condition will be trained in techniques designed to teach a typical narrative self-analysis / strengths-based approach to adversity. These techniques will include: choosing the best approach, minimizing stress, and identifying and enhancing personal strengths. Participants will be instructed on the mindset, asked to write about an instance of personal strength and share with a partner, and then guided through a short training designed to practice each skill.
Daily diary measures will be collected for 7 days following the study session and 1 week before the follow-up session. Microhit boosters will be sent to participants at self-identified high stress periods, which remind participants of the training session skills.
Participants will come for the follow-up session and provide a dried blood spot sample and complete a battery of self-report questionnaires.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Carnegie Mellon University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Full-time first-year student at Carnegie Mellon University.
- Adult (age 18+)
- Must own a data-enabled smartphone
- Scores indicating moderate to high levels of depressive symptomatology (composite score > or equal to 2 on the short-form (6-item) Beck Depression Inventory).
Exclusion Criteria:
- Potential participants who score a 0 or a 1 on the 6-item BDI section will not be eligible.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindful Response to Adversity
The treatment condition will be trained in techniques designed to teach a "mindful approach to adversity".
These techniques will include: normalizing, attention, equanimity, non-judgment, de-centering, accepting of experiences, and impermanence.
Participants will be instructed on the mindset, asked to write about an instance of non-judgment and share with a partner, and then guided through a short training designed to practice each skill.
|
Participants will attend a group training session, led by a professional instructor, about responding to adversity with an approach of mindfulness, equanimity, and non-judgment, which will include a description of the skills, a writing and sharing activity focused on the proposed approach, and a practice session.
Following the training, participants will be instructed to practice the skills that they just learned during a group version of a standard stress-induction task called the Trier Social Stress Task (the TSST-G).
|
Active Comparator: Strength-based approach to adversity
The control condition will be trained in techniques designed to teach a typical narrative self-analysis / strengths-based approach to adversity.
These techniques will include: choosing the best approach, minimizing stress, and identifying and enhancing personal strengths.
Participants will be instructed on the mindset, asked to write about an instance of personal strength and share with a partner, and then guided through a short training designed to practice each skill.
|
Participants will attend a group training session, led by a professional instructor, about responding to adversity with an approach of strengths-based, narrative self-analysis, which will include a description of the skills, a writing and sharing activity focused on the proposed approach, and a practice session.
Following the training, participants will be instructed to practice the skills that they just learned during a group version of a standard stress-induction task called the Trier Social Stress Task (the TSST-G).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily Depression
Time Frame: Change in daily depression assessed daily for seven days during week 2 and week 16 of the study.
|
In a daily diary, participants are asked at the end of the day to identify the extent to which they endorse symptoms measuring depressive symptomatology (i.e. "feeling hopeless about the future", "feeling blue") for that day. Analyses will use multilevel modeling to test for a time by condition interaction showing lower daily depressive symptomatology at post-treatment in the equanimity compared to the strength based group. |
Change in daily depression assessed daily for seven days during week 2 and week 16 of the study.
|
Depression I
Time Frame: Change in depression over 4-month period.
|
Evaluated using the validated 21-item Beck Depression Inventory (BDI), which is designed to measure characteristic attitudes and symptoms of depression. The score for each item ranges between 0-3, where 0 denotes less depression (e.g. "I do not feel sad") and 3 denotes more depression (e.g. "I am so dan and unhappy that I can't stand it"). Total score will be between 0-63, where 0 indicates no depression and 63 indicates extreme depression. The score is a total of 21 questions and the following is a typical subscale range distribution: 1-10: These ups and downs are considered normal 11-16: Mild mood disturbance 17-20: Borderline clinical depression 21-30: Moderate depression 31-40: Severe depression over 40: Extreme depression Analyses will use multilevel modeling to test for a time by condition interaction showing lower depressive symptomatology at post-treatment in the equanimity compared to the strength based treatment group. |
Change in depression over 4-month period.
|
Depression II
Time Frame: Change in depression over 4-month period.
|
Evaluated using the validated 20-item Center for Epidemiologic Studies Depression scale (CES-D), which is designed to measure characteristic attitudes and symptoms of depression. There are 20 questions and the score for each item ranges between 0-3. For most questions, a lower score indicates lack of depression and a higher score indicates high depression (e.g. in response to the statement "I felt fearful" a 0 indicates rarely and 3 indicates most or all of the time). Questions 4, 8, 12, and 16 are reverse scored. The score is the sum of the 20 questions. Possible range is 0-60. A score of 16 points or more is considered depressed. Analyses will use multilevel modeling to test for a time by condition interaction showing lower depressive symptomatology at post-treatment in the equanimity compared to the strength based treatment group. |
Change in depression over 4-month period.
|
Daily Social Connection
Time Frame: Change in daily social connection assessed daily for seven days during week 2 and week 16 of the study.
|
Following Hawkley et al. (2007) and our previous studies, end-of-day daily diary questions will assess the amount of time spent interacting with others and the extent to which social interactions throughout the day were perceived as positive. Example items: "How much time did you spend today with others, talking or listening to them?" (0 = little or none of the day to 4 = most or all of the day) and "How many positive interactions did you have today (e.g., supportive, enjoyable, rewarding, affirming)?" (0 = one, 1 = several, 2 = many). Analyses will use multilevel modeling to test for a time by condition interaction showing increased daily social connection at post-treatment in the equanimity compared to the strength based group. |
Change in daily social connection assessed daily for seven days during week 2 and week 16 of the study.
|
Daily Belonging
Time Frame: Change in loneliness over 4-month period.
|
End-of-day daily diary questions will measure feelings of belonging and closeness at school. Example items: "I felt like I belong in school" and "I felt like no one really knew me well at school (reverse-scored)" (0= Not at all, 4= Extremely). Analyses will use multilevel modeling to test for a time by condition interaction showing increased daily social belonging at post-treatment in the equanimity compared to the strength based group. |
Change in loneliness over 4-month period.
|
Loneliness
Time Frame: Change in loneliness over 4-month period.
|
Evaluated using the University of California, Los Angeles (UCLA) Loneliness Scale. The University of California, Los Angeles (UCLA) Loneliness scale is designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as either A ("I always feels this way"), O ("I often feel this way"), S ("I sometimes feel this way"), R ("I rarely feel this way"), N ("I never feel this way"). Scores are summed from each item and higher scores indicate greater degrees of loneliness. Scores of 15-20 indicate average level of loneliness; 21-30 indicate frequent loneliness; 31-40 indicate severe loneliness. Analyses will use multilevel modeling to test for a time by condition interaction showing decreased loneliness at post-treatment in the equanimity compared to the strength based group. |
Change in loneliness over 4-month period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Academic performance
Time Frame: Change in GPA between semester immediately prior to enrollment and semester during enrollment in the study (approximately 5 months).
|
Academic performance will be assessed using Grade Point Average (GPA).
Analyses will use multilevel modeling to test for a time by condition interaction higher GPA at post treatment (and follow-up) in the equanimity compared to the strength based group.
|
Change in GPA between semester immediately prior to enrollment and semester during enrollment in the study (approximately 5 months).
|
Occurrences of Daily Acceptance
Time Frame: Assessed daily for seven days during week 2 and week 16 of the study.
|
End-of-day perceptions of daily acceptance (used in Chin et al., under review) will be measured (Example questions" Today, I was able to accept myself as I am", "Today, I've been judging the situation that I am in or the events that are occurring as good or bad"). Analyses will use multilevel modeling to test for a time by condition interaction showing increased acceptance and non-judgment at post-treatment in the equanimity compared to the strength based group. |
Assessed daily for seven days during week 2 and week 16 of the study.
|
Physical Activity (FitBit)
Time Frame: Assessed daily during week 2-17 of the study.
|
Activity data for number of steps will be assessed using a FitBit device worn by participants. Multi-level models will test for time by treatment interactions showing increased physical activity outcomes over time in the equanimity compared to the strength based group. |
Assessed daily during week 2-17 of the study.
|
Sleep (FitBit)
Time Frame: Assessed daily during week 2-17 of the study.
|
Activity data for sleep will be assessed using a FitBit device worn by participants. Multi-level models will test for time by treatment interactions showing increased sleep outcomes over time in the equanimity compared to the strength based group. |
Assessed daily during week 2-17 of the study.
|
Concentrations of pro-inflammatory gene expression
Time Frame: Change in gene expression over weeks 1 and weeks 17 of the study.
|
Gene expression measures of immune system function will be collected via dried blood spot collection method. Multi-level models will test for time by condition effects. Analyses will focus an a priori-specified gene regulation pattern involving increased expression of inflammation-related genes and decreased expression of antiviral gene - a pattern called the conserved transcriptional response to adversity (CTRA; Cole, 2012). |
Change in gene expression over weeks 1 and weeks 17 of the study.
|
Concentrations of C-Reactive Protein
Time Frame: Change in CRP over 4-month period.
|
CRP will be assessed through dried blood spots collected at baseline and post-intervention. Changes in CRP will be assessed using a time by group interaction. |
Change in CRP over 4-month period.
|
Concentrations of salivary cortisol
Time Frame: Four cortisol samples will be collected at the baseline session. One sample before and three samples after the acute stress challenge using the TSST.
|
Saliva samples will be collected before and after the TSST, and assayed for salivary cortisol determination. Salivary cortisol will be analyzed both using area-under-the-curve (AUC) and mixed effects linear models, testing for a time by condition interaction showing that equanimity group has reduced cortisol reactivity to the TSST over time relative to the strength based group. |
Four cortisol samples will be collected at the baseline session. One sample before and three samples after the acute stress challenge using the TSST.
|
Perceived Stress
Time Frame: Change in perceived stress over 4-month period.
|
Evaluated using Perceived Stress Scale (PSS). The PSS measures the degree to which situations in one's life are appraised as stressful. Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress. Analyses will use multilevel modeling to test for a time by condition interaction showing decreased reported stress at post-treatment in the equanimity compared to the strength based group. |
Change in perceived stress over 4-month period.
|
Subjective Social Status
Time Frame: Measured at baseline only.
|
Created by health psychologist Nancy Adler and team (2000), the MacArthur Scale of Subjective Social Status is a single-item measure that assesses a person's perceived rank relative to others in their group.
Respondents view a drawing of a ladder with 10 rungs, and either read that the ladder represents where people stand in society.
Respondents further read : "At the top of the ladder are the people who are the best off, those who have the most money, most education, and best jobs.
At the bottom are the people who are the worst off, those who have the least money, least education, worst jobs, or no job.
Please place an 'X' on the rung that best represents where you think you stand on the ladder.".
Rungs are translated to numbers (1-10).
Choosing higher rungs of the ladder (e.g.
10) indicates perception of higher social status and choosing lower rungs of the ladder (e.g. 1) indicates lower social status.
|
Measured at baseline only.
|
Daily Resilience using the Brief Resilience Scale
Time Frame: Assessed daily for seven days during week 2 and week 16 of the study.
|
End-of-day items will measure resilience over the course of the day.
The Brief Resilience Scale (BRS, Smith et al. 2008) is a 6-item survey that assesses the ability to bounce back or recover from stress (e.g.
"It does not take me long to recover from a stressful event.").
Some items are reverse scored and then all items are summed.
Higher scores reflect more resilience.
Analyses will use multilevel modeling to test for a time by condition interaction showing increased resilience in daily life at post-treatment in the equanimity compared to the strength based group.
|
Assessed daily for seven days during week 2 and week 16 of the study.
|
Daily Occurrence of Stress and Successful Coping Scale
Time Frame: Assessed daily for seven days during week 2 and week 16 of the study.
|
End-of-day items will measure the perception of stress occurrence and types (e.g. "concerns about academic performance" or "family concerns") and overall perceptions of coping ability scale (e.g. Since the last survey, to what extent do you feel like your demands exceeded your ability to cope with them?") over the course of the day. Scale ranges from 0="not at all true" to 4 = "extremely true"), where higher scores indicate less successful coping (item 3 reverse scored). Analyses will use multilevel modeling to test for a time by condition interaction showing decreased stress (and increased coping) in daily life at post-treatment in the equanimity compared to the strength based group. |
Assessed daily for seven days during week 2 and week 16 of the study.
|
Daily State Mindfulness Scale
Time Frame: Assessed daily for seven days during week 2 and week 16 of the study.
|
End-of-day items will measure state mindfulness over the course of the day (e.g. "I was thinking about something other than what I was currently doing" is reverse scored). The scale ranges from 0=Strongly agree to 5= Strongly disagree. Higher scores indicate higher state mindfulness. Analyses will use multilevel modeling to test for a time by condition interaction showing increased mindfulness in daily life at post-treatment in the equanimity compared to the strength based group. |
Assessed daily for seven days during week 2 and week 16 of the study.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 182R07SM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Mindful response to adversity brief training
-
University of MichiganCompletedPregnancy | Weight GainUnited States
-
University of Kansas Medical CenterCompletedPulmonary Disease, Chronic Obstructive | Tobacco SmokingUnited States
-
Universidad Católica del MauleRecruitingHypertension | Physical ExerciseChile
-
Kaiser PermanenteNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Weill Medical College of Cornell UniversityCompletedGastric Cancer | Esophageal CancerUnited States